Biotechnology Oversight Coordination Act of 2024

The Biotechnology Oversight Coordination Act of 2024 establishes a federal committee to coordinate oversight of biotechnology products (such as those from plants, animals, and microorganisms) across agencies like the USDA, FDA, and EPA. The committee must create a unified process to determine if a product could have occurred naturally - reducing unnecessary regulation - and streamline regulatory timelines to cut delays and duplication. It will report annually to Congress on progress, including data on review durations and steps to improve efficiency for developers. The bill aims to enhance coordination without altering existing safety standards for biotech products, excluding human medical products regulated solely by the FDA.